The DOI matches its Crossref record; 443 of the 443 references it cites were found in a registry or an index.
Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Open accessAbstract
BACKGROUND: Researchers have suggested that omega-3 polyunsaturated fatty acids from oily fish (long-chain omega-3 (LCn3), including eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA)), as well as from plants (alpha-linolenic acid (ALA)) benefit cardiovascular health. Guidelines recommend increasing omega-3-rich foods, and sometimes supplementation, but recent trials have not confirmed this. OBJECTIVES: To assess effects of increased intake of fish- and plant-based omega-3 for all-cause mortality, cardiovascular (CVD) events, adiposity and lipids. SEARCH METHODS: We searched CENTRAL, MEDLINE and Embase to April 2017, plus ClinicalTrials.gov and World Health Organization International Clinical Trials Registry to September 2016, with no language restrictions. We handsearched systematic review references and bibliographies and contacted authors. SELECTION CRITERIA: We included randomised controlled trials (RCTs) that lasted at least 12 months and compared supplementation and/or advice to increase LCn3 or ALA intake versus usual or lower intake. DATA COLLECTION AND ANALYSIS: Two review authors independently assessed studies for inclusion, extracted data and assessed validity. We performed separate random-effects meta-analysis for ALA and LCn3 interventions, and assessed dose-response relationships through meta-regression. MAIN RESULTS: We included 79 RCTs (112,059 participants) in this review update and found that 25 were at low summary risk of bias. Trials were of 12 to 72 months' duration and included adults at varying cardiovascular risk, mainly in high-income countries. Most studies assessed LCn3 supplementation with capsules, but some used LCn3- or ALA-rich or enriched foods or dietary advice compared to placebo or usual diet. LCn3 doses ranged from 0.5g/d LCn3 to > 5 g/d (16 RCTs gave at least 3g/d LCn3).Meta-analysis and sensitivity analyses suggested little or no effect of increasing LCn3 on all-cause mortality (RR 0.98, 95% CI 0.90 to 1.03, 92,653 participants; 8189 deaths in 39 trials, high-quality evidence), cardiovascular mortality (RR 0.95, 95% CI 0.87 to 1.03, 67,772 participants; 4544 CVD deaths in 25 RCTs), cardiovascular events (RR 0.99, 95% CI 0.94 to 1.04, 90,378 participants; 14,737 people experienced events in 38 trials, high-quality evidence), coronary heart disease (CHD) mortality (RR 0.93, 95% CI 0.79 to 1.09, 73,491 participants; 1596 CHD deaths in 21 RCTs), stroke (RR 1.06, 95% CI 0.96 to 1.16, 89,358 participants; 1822 strokes in 28 trials) or arrhythmia (RR 0.97, 95% CI 0.90 to 1.05, 53,796 participants; 3788 people experienced arrhythmia in 28 RCTs). There was a suggestion that LCn3 reduced CHD events (RR 0.93, 95% CI 0.88 to 0.97, 84,301 participants; 5469 people experienced CHD events in 28 RCTs); however, this was not maintained in sensitivity analyses - LCn3 probably makes little or no difference to CHD event risk. All evidence was of moderate GRADE quality, except as noted.Increasing ALA intake probably makes little or no difference to all-cause mortality (RR 1.01, 95% CI 0.84 to 1.20, 19,327 participants; 459 deaths, 5 RCTs),cardiovascular mortality (RR 0.96, 95% CI 0.74 to 1.25, 18,619 participants; 219 cardiovascular deaths, 4 RCTs), and CHD mortality (1.1% to 1.0%, RR 0.95, 95% CI 0.72 to 1.26, 18,353 participants; 193 CHD deaths, 3 RCTs) and ALA may make little or no difference to CHD events (RR 1.00, 95% CI 0.80 to 1.22, 19,061 participants, 397 CHD events, 4 RCTs, low-quality evidence). However, increased ALA may slightly reduce risk of cardiovascular events (from 4.8% to 4.7%, RR 0.95, 95% CI 0.83 to 1.07, 19,327 participants; 884 CVD events, 5 RCTs, low-quality evidence with greater effects in trials at low summary risk of bias), and probably reduces risk of arrhythmia (3.3% to 2.6%, RR 0.79, 95% CI 0.57 to 1.10, 4,837 participants; 141 events, 1 RCT). Effects on stroke are unclear.Sensitivity analysis retaining only trials at low summary risk of bias moved effect sizes towards the null (RR 1.0) for all LCn3 primary outcomes except arrhythmias, but for most ALA outcomes, effect sizes moved to suggest protection. LCn3 funnel plots suggested that adding in missing studies/results would move effect sizes towards null for most primary outcomes. There were no dose or duration effects in subgrouping or meta-regression.There was no evidence that increasing LCn3 or ALA altered serious adverse events, adiposity or lipids, except LCn3 reduced triglycerides by ˜15% in a dose-dependant way (high-quality evidence). AUTHORS' CONCLUSIONS: This is the most extensive systematic assessment of effects of omega-3 fats on cardiovascular health to date. Moderate- and high-quality evidence suggests that increasing EPA and DHA has little or no effect on mortality or cardiovascular health (evidence mainly from supplement trials). Previous suggestions of benefits from EPA and DHA supplements appear to spring from trials with higher risk of bias. Low-quality evidence suggests ALA may sli
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: Effects of Omega-3 Polyunsaturated Fatty Acids on Inflammatory Markers in COPD
Matsuyama, W., Mitsuyama, H., Watanabe, M., Oonakahara, K.-I., Higashimoto, I., Osame, M., & Arimura, K. (2005) · Chest · doi:10.1378/chest.128.6.3817 · Cited by 108 · cited 2×
“Another trial was retracted and so not included (Matsuyama 2005).”
BackgroundRetractedMeasuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Grading quality of evidence and strength of recommendations
(2004) · BMJ · doi:10.1136/bmj.328.7454.1490 · Cited by 8,477
Schulz (1995) · doi:10.1001/jama.1995.03520290060030 · Cited by 5,634
Fish Consumption, Fish Oil, Omega-3 Fatty Acids, and Cardiovascular Disease
Kris-Etherton, P. M., Harris, W. S., & Appel, L. J. (2002) · Circulation · doi:10.1161/01.cir.0000038493.65177.94 · Cited by 3,707
SCANDINAVIANSIMVASTATINSURVIVAL (1994) · The Lancet · doi:10.1016/s0140-6736(94)90566-5 · Cited by 3,645
PEDERSEN, T. R. (2004) · Atherosclerosis Supplements · doi:10.1016/j.atherosclerosissup.2004.08.027 · Cited by 3,106
de Lorgeril, M., Salen, P., Martin, J.-L., Monjaud, I., Delaye, J., & Mamelle, N. (1999) · Circulation · doi:10.1161/01.cir.99.6.779 · Cited by 2,910
Burr, M. L., Gilbert, J. F., Holliday, R. M., Elwood, P. C., Fehily, A. M., Rogers, S., Sweetnam, P. M., & Deadman, N. M. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90828-3 · Cited by 2,610
Wood, L., Egger, M., Gluud, L. L., Schulz, K. F., Jüni, P., Altman, D. G., Gluud, C., Martin, R. M., Wood, A. J. G., & Sterne, J. A. C. (2008) · BMJ · doi:10.1136/bmj.39465.451748.ad · Cited by 2,538 · cited 2×
“Wood 2008 Wood L, Egger M, Gluud LL, Schulz K, Jüni P, Altman DG, et al. Empirical evidence of bias in treatment eCect estimates in controlled trials with diCerent interventions and outcomes: meta-epidemiological study.”
BackgroundYokoyama, M., Origasa, H., Matsuzaki, M., Matsuzawa, Y., Saito, Y., Ishikawa, Y., Oikawa, S., Sasaki, J., Hishida, H., Itakura, H., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60527-3 · Cited by 2,516
Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease
de Lorgeril, M., Renaud, S., Salen, P., Monjaud, I., Mamelle, N., Martin, J. L., Guidollet, J., Touboul, P., & Delaye, J. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92580-1 · Cited by 2,122
(1999) · PubMed · Cited by 2,062
Basal insulin and cardiovascular and other outcomes in dysglycemia
The ORIGIN Trial Investigators (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1203858 · Cited by 1,636
GISSI-HF investigators (2008) · The Lancet · doi:10.1016/s0140-6736(08)61239-8 · Cited by 1,350
Marchioli, R., Barzi, F., Bomba, E., Chieffo, C., Di Gregorio, D., Di Mascio, R., Franzosi, M. G., Geraci, E., Levantesi, G., Maggioni, A. P., et al. (2002) · Circulation · doi:10.1161/01.cir.0000014682.14181.f2 · Cited by 1,311
Rizos, E. C., Ntzani, E. E., Bika, E., Kostapanos, M. S., & Elisaf, M. S. (2012) · JAMA · doi:10.1001/2012.jama.11374 · Cited by 960
The Composition of Food Consumed by Greenland Eskimos
Bang, H. O., Dyerberg, J., & Hjørne, N. (1976) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1976.tb08198.x · Cited by 944
n–3 Fatty Acids and Cardiovascular Events after Myocardial Infarction
Kromhout, D., Giltay, E. J., & Geleijnse, J. M. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1003603 · Cited by 936
n–3 Fatty Acids and Cardiovascular Outcomes in Patients with Dysglycemia
The ORIGIN Trial Investigators (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1203859 · Cited by 929
A random‐effects regression model for meta‐analysis
Berkey, C. S., Hoaglin, D. C., Mosteller, F., & Colditz, G. A. (1995) · Statistics in Medicine · doi:10.1002/sim.4780140406 · Cited by 879
Andrieu, S., Guyonnet, S., Coley, N., Cantet, C., Bonnefoy, M., Bordes, S., Bories, L., Cufi, M.-N., Dantoine, T., Dartigues, J.-F., et al. (2017) · The Lancet Neurology · doi:10.1016/s1474-4422(17)30040-6 · Cited by 838
Effect of an Enteric-Coated Fish-Oil Preparation on Relapses in Crohn's Disease
Belluzzi, A., Brignola, C., Campieri, M., Pera, A., Boschi, S., & Miglioli, M. (1996) · New England Journal of Medicine · doi:10.1056/nejm199606133342401 · Cited by 766
Docosahexaenoic Acid Supplementation and Cognitive Decline in Alzheimer Disease: A Randomized Trial
Quinn, J. F., Raman, R., Thomas, R. G., Yurko-Mauro, K., Nelson, E. B., Van Dyck, C., Galvin, J. E., Emond, J., Jack, C. R., Weiner, M., et al. (2010) · JAMA · doi:10.1001/jama.2010.1510 · Cited by 764 · cited 1×
“(Quinn 2010, p. 1910).”
Reduction in saturated fat intake for cardiovascular disease
Hooper, L., Martin, N., Abdelhamid, A., & Davey Smith, G. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011737 · Cited by 704
Self-citationHooper, L., Thompson, R. L., Harrison, R. A., Summerbell, C. D., Ness, A. R., Moore, H. J., Worthington, H. V., Durrington, P. N., Higgins, J. P. T., Capps, N. E., et al. (2006) · BMJ · doi:10.1136/bmj.38755.366331.2f · Cited by 676 · cited 2×
“[DOI: 10.1002/14651858.CD003177.pub2] Hooper 2006 Hooper L, Thompson RL, Harrison RA, Summerbell CD, Ness AR, Moore HJ, et al. Risks and benefits of omega 3 fats for mortality, cardiovascular disease, and cancer: systematic review.”
BackgroundResultInfluentialSelf-citationSavović, J., Jones, H., Altman, D., Harris, R., Jűni, P., Pildal, J., Als-Nielsen, B., Balk, E., Gluud, C., Gluud, L., et al. (2012) · Health Technology Assessment · doi:10.3310/hta16350 · Cited by 668 · cited 2×
“Savovic 2012 Savovic J, Jones H, Altman D, Harris R, Jüni P, Pildal J, et al. Influence of reported study design characteristics on intervention eCect estimates from randomised controlled trials: combined analysis of meta-epidemiological studies.”
BackgroundSingh, R. B., Dubnov, G., Niaz, M. A., Ghosh, S., Singh, R., Rastogi, S. S., Manor, O., Pella, D., & Berry, E. M. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11472-3 · Cited by 663 · cited 2×
“Singh 2002 {published data only} Pella D, Dubnov G, Singh RB, Sharma R, Berry EM, Manor O. ECects of an Indo-Mediterranean diet on the omega-6/omega-3 ratio in patients at high risk of coronary artery disease: the Indian paradox.”
BackgroundResultKatan, M. B., Deslypere, J. P., van Birgelen, A. P., Penders, M., & Zegwaard, M. (1997) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37132-7 · Cited by 638
Aung, T., Halsey, J., Kromhout, D., Gerstein, H. C., Marchioli, R., Tavazzi, L., Geleijnse, J. M., Rauch, B., Ness, A., Galan, P., et al. (2018) · JAMA Cardiology · doi:10.1001/jamacardio.2017.5205 · Cited by 632
Rauch, B., Schiele, R., Schneider, S., Diller, F., Victor, N., Gohlke, H., Gottwik, M., Steinbeck, G., Del Castillo, U., Sack, R., et al. (2010) · Circulation · doi:10.1161/circulationaha.110.948562 · Cited by 607
Physiological compartmental analysis of α-linolenic acid metabolism in adult humans
Pawlosky, R. J., Hibbeln, J. R., Novotny, J. A., & Salem, N. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31576-5 · Cited by 592
Pathogenesis and Treatment of Chronic Kidney Disease: A Review of Our Recent Basic and Clinical Data
Tomino, Y. (2014) · Kidney and Blood Pressure Research · doi:10.1159/000368458 · Cited by 566
PLASMA LIPIDS AND LIPOPROTEINS IN GREENLANDIC WEST COAST ESKIMOS
Bang, H. O., & Dyerberg, J. (1972) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1972.tb04782.x · Cited by 563
Manson, J. E., Bassuk, S. S., Lee, I.-M., Cook, N. R., Albert, M. A., Gordon, D., Zaharris, E., MacFadyen, J. G., Danielson, E., Lin, J., et al. (2012) · Contemporary Clinical Trials · doi:10.1016/j.cct.2011.09.009 · Cited by 557
Singh, R. B., Niaz, M. A., Sharma, J. P., Kumar, R., Rastogi, V., & Moshiri, M. (1997) · Cardiovascular Drugs and Therapy · doi:10.1023/a:1007757724505 · Cited by 536
Stark, K. D., Van Elswyk, M. E., Higgins, M. R., Weatherford, C. A., & Salem, N. (2016) · Progress in Lipid Research · doi:10.1016/j.plipres.2016.05.001 · Cited by 519
n–3 Fatty Acids in Patients with Multiple Cardiovascular Risk Factors
The Risk and Prevention Study Collaborative Group (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1205409 · Cited by 510
von Schacky, C., Angerer, P., Kothny, W., Theisen, K., & Mudra, H. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-7-199904060-00003 · Cited by 487
Singh, R. B., Rastogi, S. S., Verma, R., Laxmi, B., Singh, R., Ghosh, S., & Niaz, M. A. (1992) · BMJ · doi:10.1136/bmj.304.6833.1015 · Cited by 458
The Oslo Diet-Heart Study: Eleven-Year Report
LEREN, P. (1970) · Circulation · doi:10.1161/01.cir.42.5.935 · Cited by 458
Galan, P., Kesse-Guyot, E., Czernichow, S., Briancon, S., Blacher, J., Hercberg, S., & for the SU.FOL.OM3 Collaborative Group (2010) · BMJ · doi:10.1136/bmj.c6273 · Cited by 457
Chew, E. Y., Clemons, T. E., SanGiovanni, J. P., Danis, R. P., Ferris, F. L., Elman, M. J., Antoszyk, A. N., Ruby, A. J., Orth, D., Bressler, S. B., et al. (2014) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2013.7376 · Cited by 415
The Age-related Eye Disease Study 2 (AREDS2)
Chew, E. Y., Clemons, T., SanGiovanni, J. P., Danis, R., Domalpally, A., McBee, W., Sperduto, R., & Ferris, F. L. (2012) · Ophthalmology · doi:10.1016/j.ophtha.2012.05.027 · Cited by 415
Lack of benefit of dietary advice to men with angina: results of a controlled trial
Burr, M. L., Ashfield-Watt, P. A. L., Dunstan, F. D. J., Fehily, A. M., Breay, P., Ashton, T., Zotos, P. C., Haboubi, N. A. A., & Elwood, P. C. (2003) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1601539 · Cited by 409
A Controlled Trial of Fish Oil in IgA Nephropathy
Donadio, J. V., Bergstralh, E. J., Offord, K. P., Spencer, D. C., & Holley, K. E. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411033311804 · Cited by 408
Chowdhury, R., Stevens, S., Gorman, D., Pan, A., Warnakula, S., Chowdhury, S., Ward, H., Johnson, L., Crowe, F., Hu, F. B., et al. (2012) · BMJ · doi:10.1136/bmj.e6698 · Cited by 379
Raitt, M. H., Connor, W. E., Morris, C., Kron, J., Halperin, B., Chugh, S. S., McClelland, J., Cook, J., MacMurdy, K., Swenson, R., et al. (2005) · JAMA · doi:10.1001/jama.293.23.2884 · Cited by 371
Kwak (2012) · doi:10.1001/archinternmed.2012.262 · Cited by 368
de Lorgeril, M., Salen, P., Martin, J.-L., Monjaud, I., Boucher, P., & Mamelle, N. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.11.1181 · Cited by 365
Prevention of fatal arrhythmias in high-risk subjects by fish oil n-3 fatty acid intake
Leaf, A., Albert, C. M., Josephson, M., Steinhaus, D., Kluger, J., Kang, J. X., Cox, B., Zhang, H., & Schoenfeld, D. (2005) · Circulation · doi:10.1161/circulationaha.105.549527 · Cited by 364
Long chain omega-3 fatty acids and cardiovascular disease: a systematic review
Delgado-Lista, J., Perez-Martinez, P., Lopez-Miranda, J., & Perez-Jimenez, F. (2012) · British Journal of Nutrition · doi:10.1017/s0007114512001596 · Cited by 351
Cretan Mediterranean diet for prevention of coronary heart disease
Renaud, S., de Lorgeril, M., Delaye, J., Guidollet, J., Jacquard, F., Mamelle, N., Martin, J., Monjaud, I., Salen, P., & Toubol, P. (1995) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/61.6.1360s · Cited by 340
Cleland, J. G. F., Freemantle, N., Coletta, A. P., & Clark, A. L. (2006) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2005.12.003 · Cited by 320
Saito, Y., Yokoyama, M., Origasa, H., Matsuzaki, M., Matsuzawa, Y., Ishikawa, Y., Oikawa, S., Sasaki, J., Hishida, H., Itakura, H., et al. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.06.003 · Cited by 316
Browning, L. M., Walker, C. G., Mander, A. P., West, A. L., Madden, J., Gambell, J. M., Young, S., Wang, L., Jebb, S. A., & Calder, P. C. (2012) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.112.041343 · Cited by 314
Gogos, C. A., Ginopoulos, P., Salsa, B., Apostolidou, E., Zoumbos, N. C., & Kalfarentzos, F. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980115)82:2<403::aid-cncr21>3.0.co;2-1 · Cited by 311
Scorletti, E., Bhatia, L., McCormick, K. G., Clough, G. F., Nash, K., Hodson, L., Moyses, H. E., Calder, P. C., Byrne, C. D., Sheron, N., et al. (2014) · Hepatology · doi:10.1002/hep.27289 · Cited by 310
Sanyal, A. J., Abdelmalek, M. F., Suzuki, A., Cummings, O. W., & Chojkier, M. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.04.046 · Cited by 309
Hawthorne, A. B., Daneshmend, T. K., Hawkey, C. J., Belluzzi, A., Everitt, S. J., Holmes, G. K., Malkinson, C., Shaheen, M. Z., & Willars, J. E. (1992) · Gut · doi:10.1136/gut.33.7.922 · Cited by 300
Targher, G., & Byrne, C. D. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3093 · Cited by 297
Dangour, A. D., Allen, E., Elbourne, D., Fasey, N., Fletcher, A. E., Hardy, P., Holder, G. E., Knight, R., Letley, L., Richards, M., et al. (2010) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.29121 · Cited by 296
Shinto, L., Quinn, J., Montine, T., Dodge, H. H., Woodward, W., Baldauf-Wagner, S., Waichunas, D., Bumgarner, L., Bourdette, D., Silbert, L., et al. (2013) · Journal of Alzheimer's Disease · doi:10.3233/jad-130722 · Cited by 288 · cited 4×
“We tried to contact 72 of the 79 included studies (all except Baldassarre 2006; HERO 2009; Mita 2007; Nutristroke 2009; Özaydin 2011; Shinto 2014; Sofi 2010).”
BackgroundInfluentialBrouwer, I. A., Zock, P. L., Camm, A. J., Böcker, D., Hauer, R. N. W., Wever, E. F. D., Dullemeijer, C., Ronden, J. E., Katan, M. B., Lubinski, A., et al. (2006) · JAMA · doi:10.1001/jama.295.22.2613 · Cited by 287
Feagan, B. G., Sandborn, W. J., Mittmann, U., Bar-Meir, S., D’Haens, G., Bradette, M., Cohen, A., Dallaire, C., Ponich, T. P., McDonald, J. W. D., et al. (2008) · JAMA · doi:10.1001/jama.299.14.1690 · Cited by 275
Common purslane: a source of omega-3 fatty acids and antioxidants.
Simopoulos, A. P., Norman, H. A., Gillaspy, J. E., & Duke, J. A. (1992) · Journal of the American College of Nutrition · doi:10.1080/07315724.1992.10718240 · Cited by 267
Omega 3 fatty acids for prevention and treatment of cardiovascular disease
Hooper, L., Harrison, R. A., Summerbell, C. D., Moore, H., Worthington, H. V., Ness, A., Capps, N., Davey Smith, G., Riemersma, R., & Ebrahim, S. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003177.pub2 · Cited by 264
Self-citationKremer, J. M., Lawrence, D. A., Petrillo, G. F., Litts, L. L., Mullaly, P. M., Rynes, R. I., Stocker, R. P., Parhami, N., Greenstein, N. S., Fuchs, B. R., et al. (1995) · Arthritis & Rheumatism · doi:10.1002/art.1780380813 · Cited by 259
Long‐term effect of omega‐3 fatty acid supplementation in active rheumatoid arthritis
Geusens, P., Wouters, C., Nijs, J., Jiang, Y., & Dequeker, J. (1994) · Arthritis & Rheumatism · doi:10.1002/art.1780370608 · Cited by 258
MAPT STUDY: A MULTIDOMAIN APPROACH FOR PREVENTING ALZHEIMER’S DISEASE: DESIGN AND BASELINE DATA
Vellas, B., Gillette-Guyonnet, S., Touchon, J., Dantoine, T., Dartigues, J. F., Cuffi, M. N., Bordes, S., Gasnier, Y., Robert, P., Bories, L., et al. (2014) · The Journal Of Prevention of Alzheimer's Disease · doi:10.14283/jpad.2014.34 · Cited by 255
Effect of dietary supplementation with n-3 fatty acids on coronary artery bypass graft patency
Eritsland, J., Arnesen, H., Grønseth, K., Fjeld, N. B., & Abdelnoor, M. (1996) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)89130-8 · Cited by 252
Dodin, S., Lemay, A., Jacques, H., Légaré, F., Forest, J.-C., & Mâsse, B. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1148 · Cited by 244
Tavazzi, L., Tognoni, G., Franzosi, M. G., Latini, R., Maggioni, A. P., Marchioli, R., Nicolosi, G. L., & Porcu, M. (2004) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2004.03.001 · Cited by 240
Papanikolaou, Y., Brooks, J., Reider, C., & Fulgoni, V. L. (2014) · Nutrition Journal · doi:10.1186/1475-2891-13-31 · Cited by 240
de Lorgeril, M., Salen, P., Martin, J.-L., Mamelle, N., Monjaud, I., Touboul, P., & Delaye, J. (1996) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(96)00280-x · Cited by 230
Argo, C. K., Patrie, J. T., Lackner, C., Henry, T. D., de Lange, E. E., Weltman, A. L., Shah, N. L., Al-Osaimi, A. M., Pramoonjago, P., Jayakumar, S., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.08.036 · Cited by 224
Belch, J. J., Ansell, D., Madhok, R., O'Dowd, A., & Sturrock, R. D. (1988) · Annals of the Rheumatic Diseases · doi:10.1136/ard.47.2.96 · Cited by 220
(1966) · PubMed · Cited by 218
Relationships between plasma fatty acid composition and coronary artery disease.
Itakura, H., Yokoyama, M., Matsuzaki, M., Saito, Y., Origasa, H., Ishikawa, Y., Oikawa, S., Sasaki, J., Hishida, H., Kita, T., et al. (2011) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.5876 · Cited by 218
Tanaka, K., Ishikawa, Y., Yokoyama, M., Origasa, H., Matsuzaki, M., Saito, Y., Matsuzawa, Y., Sasaki, J., Oikawa, S., Hishida, H., et al. (2008) · Stroke · doi:10.1161/strokeaha.107.509455 · Cited by 217
Nodari, S., Triggiani, M., Campia, U., Manerba, A., Milesi, G., Cesana, B. M., Gheorghiade, M., & Dei Cas, L. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.11.017 · Cited by 217
Controlled trial of fish oil for regression of human coronary atherosclerosis
Sacks, F. M., Stone, P. H., Gibson, C. M., Silverman, D. I., Rosner, B., & Pasternak, R. C. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00095-l · Cited by 216
Bemelmans, W. J., Broer, J., Feskens, E. J., Smit, A. J., Muskiet, F. A., Lefrandt, J. D., Bom, V. J., May, J. F., & Meyboom-de Jong, B. (2002) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/75.2.221 · Cited by 213
Low fat dietary intervention with ω-3 fatty acid supplementation in multiple sclerosis patients
Weinstock-Guttman, B., Baier, M., Park, Y., Feichter, J., Lee-Kwen, P., Gallagher, E., Venkatraman, J., Meksawan, K., Deinehert, S., Pendergast, D., et al. (2005) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2005.05.024 · Cited by 212
Lorenz-Meyer, H., Bauer, P., Nicolay, C., Schulz, B., Purrmann, J., Fleig, W. E., Scheurlen, C., Koop, I., Pudel, V., & Carr, L. (1996) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529609010352 · Cited by 211
Macsai, M. S. (2008) · PubMed · Cited by 209
Potent Antihypertensive Action of Dietary Flaxseed in Hypertensive Patients
Rodriguez-Leyva, D., Weighell, W., Edel, A. L., LaVallee, R., Dibrov, E., Pinneker, R., Maddaford, T. G., Ramjiawan, B., Aliani, M., Guzman, R., et al. (2013) · Hypertension · doi:10.1161/hypertensionaha.113.02094 · Cited by 207
ω-3 Fatty acids: Comparison of plant and seafood sources in human nutrition
Nettleton, J. A. (1991) · Journal of the American Dietetic Association · doi:10.1016/s0002-8223(21)01118-4 · Cited by 207
The ORIGIN Trial Investigators (2008) · American Heart Journal · doi:10.1016/j.ahj.2007.09.009 · Cited by 204
Nilsen, D. W., Albrektsen, G., Landmark, K., Moen, S., Aarsland, T., & Woie, L. (2001) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/74.1.50 · Cited by 203
Omega 3 Fatty Acids and Cardiovascular Outcomes: Systematic Review and Meta-Analysis
Kotwal, S., Jun, M., Sullivan, D., Perkovic, V., & Neal, B. (2012) · Circulation: Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.112.966168 · Cited by 201 · cited 3×
“…or ALA, are consistent with many further high-quality recent systematic reviews (Campbell 2013; Chowdhury 2012; Enns 2014; He 2013; Khoueiry 2013; Kotwal 2012; Kwak 2012; Mariani 2013; Rizos 2012; Zheng 2014), and they confirm and expand on the findings of earlier versions of this review (Hooper…”
BackgroundResultSharp, S. J. (1998) · Stata technical bulletin · Cited by 198
Torjesen, P. A., Birkeland, K. I., Anderssen, S. A., Hjermann, I., Holme, I., & Urdal, P. (1997) · Diabetes Care · doi:10.2337/diacare.20.1.26 · Cited by 198
Effect of dietary α-linolenic acid on thrombotic risk factors in vegetarian men
Li, D., Sinclair, A., Wilson, A., Nakkote, S., Kelly, F., Abedin, L., Mann, N., & Turner, A. (1999) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/69.5.872 · Cited by 197
Chew, E. Y., Clemons, T. E., Agrón, E., Launer, L. J., Grodstein, F., & Bernstein, P. S. (2015) · JAMA · doi:10.1001/jama.2015.9677 · Cited by 191
Calcium, gamma-linolenic acid and eicosapentaenoic acid supplementation in senile osteoporosis
Kruger, M. C., Coetzer, H., de Winter, R., Gericke, G., & van Papendorp, D. H. (1998) · Aging Clinical and Experimental Research · doi:10.1007/bf03339885 · Cited by 188
Sacks, F. M., Pasternak, R. C., Gibson, C. M., Rosner, B., & Stone, P. H. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90506-1 · Cited by 187
Berson, E. L. (2004) · Archives of Ophthalmology · doi:10.1001/archopht.122.9.1306 · Cited by 183
Galarraga, B., Ho, M., Youssef, H. M., Hill, A., McMahon, H., Hall, C., Ogston, S., Nuki, G., & Belch, J. J. F. (2008) · Rheumatology · doi:10.1093/rheumatology/ken024 · Cited by 183
Bates, D., Cartlidge, N. E., French, J. M., Jackson, M. J., Nightingale, S., Shaw, D. A., Smith, S., Woo, E., Hawkins, S. A., & Millar, J. H. (1989) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.52.1.18 · Cited by 181
Byrne, C. D., & Targher, G. (2014) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.114.303034 · Cited by 179
Berson, E. L. (2004) · Archives of Ophthalmology · doi:10.1001/archopht.122.9.1297 · Cited by 175
Matsuzaki, M., Yokoyama, M., Saitō, Y., Origasa, H., Ishikawa, Y., Oikawa, S., Sasaki, J., Hishida, H., Itakura, H., Kita, T., et al. (2009) · Circulation Journal · doi:10.1253/circj.cj-08-1197 · Cited by 166
Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease
Abdelhamid, A. S., Martin, N., Bridges, C., Brainard, J. S., Wang, X., Brown, T. J., Hanson, S., Jimoh, O. F., Ajabnoor, S. M., Deane, K. H., et al. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012345.pub2 · Cited by 165
Self-citationProudman, S. M., James, M. J., Spargo, L. D., Metcalf, R. G., Sullivan, T. R., Rischmueller, M., Flabouris, K., Wechalekar, M. D., Lee, A. T., & Cleland, L. G. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204145 · Cited by 163
Torkildsen, Ø., Wergeland, S., Bakke, S. J., Beiske, A. G., Bjerve, K. S., Hovdal, H., Midgard, R., Lilleås, F., Pedersen, T., Bjørnarå, B. T., et al. (2012) · Archives of Neurology · doi:10.1001/archneurol.2012.283 · Cited by 162
LAU, C. S., MORLEY, K. D., & BELCH, J. J. F. (1993) · Rheumatology · doi:10.1093/rheumatology/32.11.982 · Cited by 161
Tapsell, L. C., Batterham, M. J., Teuss, G., Tan, S.-Y., Dalton, S., Quick, C. J., Gillen, L. J., & Charlton, K. E. (2009) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2009.19 · Cited by 157
Oral Docosahexaenoic Acid in the Prevention of Exudative Age-Related Macular Degeneration
Souied, E. H., Delcourt, C., Querques, G., Bassols, A., Merle, B., Zourdani, A., Smith, T., & Benlian, P. (2013) · Ophthalmology · doi:10.1016/j.ophtha.2013.01.005 · Cited by 157
Lutein/Zeaxanthin for the Treatment of Age-Related Cataract
Chew, E. Y. (2013) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2013.4412 · Cited by 156
Mita, T., Watada, H., Ogihara, T., Nomiyama, T., Ogawa, O., Kinoshita, J., Shimizu, T., Hirose, T., Tanaka, Y., & Kawamori, R. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.03.005 · Cited by 153
Omega-6 fats for the primary and secondary prevention of cardiovascular disease
Hooper, L., Al-Khudairy, L., Abdelhamid, A. S., Rees, K., Brainard, J. S., Brown, T. J., Ajabnoor, S. M., O'Brien, A. T., Winstanley, L. E., Donaldson, D. H., et al. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011094.pub3 · Cited by 153
Self-citationOmega-3 Fatty Acids for the Prevention of Recurrent Symptomatic Atrial Fibrillation
Macchia, A., Grancelli, H., Varini, S. D., Nul, D. R., Laffaye, N., Mariani, J. A., Ferrante, D., Badra, R., Figal, J. C., Ramos, S., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.11.021 · Cited by 152
Ramírez-Ramírez, V., Macías-Islas, M. Á., Ortíz, G. G., Pacheco-Moisés, F. P., Torres-Sánchez, E. D., Sorto-Gómez, T. E., Cruz-Ramos, J. A., Orozco-Aviña, G., & de la Rosa, A. D. J. C. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/709493 · Cited by 151
Describing reporting guidelines for health research: a systematic review
Moher, D., Weeks, L., Ocampo, M., Seely, D., Sampson, M., Altman, D. G., Schulz, K. F., Miller, D., Simera, I., Grimshaw, J., et al. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.09.013 · Cited by 151
Fish oil in knee osteoarthritis: a randomised clinical trial of low dose versus high dose
Hill, C. L., MARCH, L. M., Aitken, D. A., Lester, S. E., Battersby, R., Hynes, K., Fedorova, T., Proudman, S., James, M. J., Cleland, L. G., et al. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2014-207169 · Cited by 147
The UK Women's Cohort Study: comparison of vegetarians, fish-eaters and meat-eaters
Cade, J. E., Burley, V. J., Greenwood, D. C., & UK Women's Cohort Study Steering Group (2004) · Public Health Nutrition · doi:10.1079/phn2004620 · Cited by 147
Masson, S., Latini, R., Milani, V., Moretti, L., Rossi, M. G., Carbonieri, E., Frisinghelli, A., Minneci, C., Valisi, M., Maggioni, A. P., et al. (2009) · Circulation Heart Failure · doi:10.1161/circheartfailure.109.881805 · Cited by 147
Fish, human health and marine ecosystem health: policies in collision
Brunner, E. J., Jones, P. J. S., Friel, S., & Bartley, M. (2009) · International Journal of Epidemiology · doi:10.1093/ije/dyn157 · Cited by 147
Khan, F., Elherik, K., Bolton-Smith, C., Barr, R., Hill, A., Murrie, I., & Belch, J. J. F. (2003) · Cardiovascular Research · doi:10.1016/s0008-6363(03)00395-x · Cited by 145
Caligiuri, S. P. B., Aukema, H. M., Ravandi, A., Guzman, R., Dibrov, E., & Pierce, G. N. (2014) · Hypertension · doi:10.1161/hypertensionaha.114.03179 · Cited by 144
Santoro, A., Pini, E., Scurti, M., Palmas, M. G., Berendsen, A. A. M., Brzozowska, A., Pietruszka, B., Szczecińska, A., Cano, N., Meunier, N., et al. (2013) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2013.12.001 · Cited by 144
Dodin, S., Cunnane, S. C., Mâsse, B., Lemay, A., Jacques, H., Asselin, G., Tremblay-Mercier, J., Marc, I., Lamarche, B., Légaré, F., et al. (2008) · Nutrition · doi:10.1016/j.nut.2007.09.003 · Cited by 142
Ethyl-EPA in Huntington disease
Puri, B. K., Leavitt, B. R., Hayden, M. R., Ross, C. A., Rosenblatt, A., Greenamyre, J. T., Hersch, S. M., Vaddadi, K. S., Sword, A., Horrobin, D. F., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000169025.09670.6d · Cited by 141
Effect of a Fish Oil Diet on Asthma: Results of a 1-Year Double-Blind Study
Dry, J., & Vincent, D. (2009) · International Archives of Allergy and Applied Immunology · doi:10.1159/000235421 · Cited by 136
Tuttle, K. R., Shuler, L. A., Packard, D. P., Milton, J. E., Daratha, K. B., Bibus, D. M., & Short, R. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.01.038 · Cited by 134
Heidt, M. C., Vician, M., Stracke, S., Stadlbauer, T. H. W., Grebe, M., Boening, A., Vogt, P. R., & Erdogan, A. (2009) · The Thoracic and Cardiovascular Surgeon · doi:10.1055/s-0029-1185301 · Cited by 133
Calabresi, L., Villa, B., Canavesi, M., Sirtori, C. R., James, R. W., Bernini, F., & Franceschini, G. (2004) · Metabolism · doi:10.1016/j.metabol.2003.09.007 · Cited by 132 · cited 2×
“[DOI: 10.1079/PHN2004620] Calabresi 2004 Calabresi L, Villa B, Canavesi M, Sirtori CR, James RW, Bernini F, et al. An omega-3 polyunsaturated fatty acid concentrate increases plasma high-density lipoprotein 2 cholesterol and paraoxonase levels in patients with familial combined hyperlipidemia.”
BackgroundInfluentialMarchioli, R., Schweiger, C., Tavazzi, L., & Valagussa, F. (2001) · Lipids · doi:10.1007/s11745-001-0694-8 · Cited by 131
Pro- and anti-inflammatory cytokines in healthy volunteers fed various doses of fish oil for 1 year
BLOK, W. L., DESLYPERE, J. ‐., DEMACKER, P. N. M., VAN DER VEN‐JONGEKRIJG, J., HECTORS, M. P. C., VAN DER MEER, J. W. M., & KATAN, M. B. (1997) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.1997.2240775.x · Cited by 129
Burr, M. L., Holliday, R. M., FEHILY, A. M., & WHITEHEAD, P. J. (1992) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a060141 · Cited by 129
Hjerkinn, E. M., Seljeflot, I., Ellingsen, I., Berstad, P. M., Hjermann, I., Sandvik, L., & Arnesen, H. (2005) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/81.3.583 · Cited by 128
N-3 fatty acids only delay early relapse of ulcerative colitis in remission
Loeschke, K., Ueberschaer, B., Pietsch, A., Gruber, E., Ewe, K., Wiebecke, B., Heldwein, W., & Lorenz, R. L. (1996) · Digestive Diseases and Sciences · doi:10.1007/bf02093614 · Cited by 127
Yokoyama, M., & Origasa, H. (2003) · American Heart Journal · doi:10.1016/s0002-8703(03)00367-3 · Cited by 127
Oikawa, S., Yokoyama, M., Origasa, H., Matsuzaki, M., Matsuzawa, Y., Saito, Y., Ishikawa, Y., Sasaki, J., Hishida, H., Itakura, H., et al. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.03.029 · Cited by 125
Scorletti, E., West, A. L., Bhatia, L. S., Hoile, S. P., McCormick, K. G., Burdge, G. C., Lillycrop, K. A., Clough, G. F., Calder, P. C., & Byrne, C. D. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.07.036 · Cited by 124
Suspected research fraud: difficulties of getting at the truth
White, C. (2005) · BMJ · doi:10.1136/bmj.331.7511.281 · Cited by 124
Bemelmans, W. J. E., Lefrandt, J. D., Feskens, E. J. M., Haelst, P. L. V., Broer, J., Meyboom-de Jong, B., May, J. F., Tervaert, J. W. C., & Smit, A. J. (2004) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1601938 · Cited by 123
Leaf, D. A., CONNOR, W. E., Barstad, L., & Sexton, G. J. (1995) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/62.1.68 · Cited by 123
Guyonnet, S., Andrieu, S., DANTOINE, T. F., Dartigues, J., Touchon, J., Vellas, B. J., & MAPT Study Group (2009) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2009.01.008 · Cited by 123
Sofi, F., Giangrandi, I., Cesari, F., Corsani, I., Abbate, R., Gensini, G. F., & Casini, A. (2010) · International Journal of Food Sciences and Nutrition · doi:10.3109/09637486.2010.487480 · Cited by 122
Geleijnse, J. M., Giltay, E. J., Schouten, E. G., de Goede, J., Griep, L. M. O., Teitsma-Jansen, A., Katan, M., & Kromhout, D. (2010) · American Heart Journal · doi:10.1016/j.ahj.2009.12.033 · Cited by 121
Brouwer, I. A., Raitt, M. H., Dullemeijer, C., Kraemer, D. F., Zock, P. L., Morris, C., Katan, M. B., Connor, W. E., Camm, J. A., Schouten, E. G., et al. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehp003 · Cited by 120
Kromhout, D., Geleijnse, J. M., de Goede, J., Griep, L. M. O., Mulder, B. J. M., de Boer, M., Deckers, J. W., Boersma, E. H., Zock, P. L., & Giltay, E. J. (2011) · Diabetes Care · doi:10.2337/dc11-0896 · Cited by 119
Tomer, A., Kasey, S., Connor, W., Clark, S., Harker, L. A., & Eckman, J. R. (2001) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1615948 · Cited by 118
Bonds, D. E., Harrington, M., Worrall, B. B., Bertoni, A. G., Eaton, C. B., Hsia, J., Robinson, J., Clemons, T. E., Fine, L. J., & Chew, E. Y. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2014.328 · Cited by 118
Scott, C. B., Littlefield, N. D., Chason, J. D., Bunker, M. P., & Asselin, E. M. (2006) · Nutrition & Metabolism · doi:10.1186/1743-7075-3-1 · Cited by 118
Mariani, J. A., Doval, H. C., Nul, D. R., Varini, S. D., Grancelli, H., Ferrante, D., Tognoni, G., & Macchia, A. (2013) · Journal of the American Heart Association · doi:10.1161/jaha.112.005033 · Cited by 117
Geleijnse, J. M., Giltay, E. J., & Kromhout, D. (2011) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2011.06.002 · Cited by 116
Dawczynski, J., Jentsch, S., Schweitzer, D., Hammer, M., Lang, G. E., & Strobel, J. (2013) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-013-2376-6 · Cited by 113
Circulating Omega-3 Fatty Acids and Neovascular Age-Related Macular Degeneration
Merle, B. M. J., Benlian, P., Puche, N., Bassols, A., Delcourt, C., & Souied, E. H. (2014) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.14-13916 · Cited by 113
Whelton, P., Kumanyika, S., Cook, N. R., Cutler, J., Borhani, N., Hennekens, C. H., Kuller, L. H., Langford, H. G., Jones, D., Satterfield, S., et al. (1997) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/65.2.652s · Cited by 112
Ness, A., Hughes, J., Elwood, P., Whitley, E., Smith, G., & Burr, M. (2002) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1601342 · Cited by 111
Nodari, S., Triggiani, M., Campia, U., Manerba, A., Milesi, G., Cesana, B. M., Gheorghiade, M., & Cas, L. D. (2011) · Circulation · doi:10.1161/circulationaha.111.022194 · Cited by 111
Sanders, T. A. B., Hall, W. L., Maniou, Z., Lewis, F., Seed, P. T., & Chowienczyk, P. (2011) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.111.018036 · Cited by 108
Eritsland, J., Arnesen, H., Seljeflot, I., & Kierulf, P. (1995) · Blood Coagulation & Fibrinolysis · doi:10.1097/00001721-199502000-00003 · Cited by 107
Edel, A. L., Rodriguez-Leyva, D., Maddaford, T. G., Caligiuri, S. P., Austria, J. A., Weighell, W., Guzman, R., Aliani, M., & Pierce, G. N. (2015) · The Journal of Nutrition · doi:10.3945/jn.114.204594 · Cited by 106
Hjerkinn, E. M., Abdelnoor, M., Breivik, L., Bergengen, L., Ellingsen, I., Seljeflot, I., Aase, O., Klemsdal, T. O., Hjermann, I., & Arnesen, H. (2006) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/01.hjr.0000209817.28444.fb · Cited by 106
EICOSAPENTAENOIC ACID AND IgA NEPHROPATHY
Hamazaki, T., Tateno, S., & Shishido, H. (1984) · The Lancet · doi:10.1016/s0140-6736(84)92355-9 · Cited by 105
Terano, T., Fujishiro, S., Ban, T., Yamamoto, K., Tanaka, T., Noguchi, Y., Tamura, Y., Yazawa, K., & Hirayama, T. (1999) · Lipids · doi:10.1007/bf02562338 · Cited by 105
Walker, C. G., West, A. L., Browning, L. M., Madden, J., Gambell, J., Jebb, S. A., & Calder, P. C. (2015) · Nutrients · doi:10.3390/nu7085285 · Cited by 104
Baseline characteristics of participants in the VITamin D and OmegA-3 TriaL (VITAL)
Bassuk, S. S., Manson, J. E., Lee, I.-M. M., Cook, N. R., Christen, W. G., Bubes, V. Y., Gordon, D., Copeland, T., Friedenberg, G., D’Agostino, D., et al. (2016) · Contemporary Clinical Trials · doi:10.1016/j.cct.2015.12.022 · Cited by 102
NEUROPSYCHOLOGICAL PROFILE OF “COGNITIVE FRAILTY” SUBJECTS IN MAPT STUDY
Delrieu, J., Andrieu, S., Pahor, M., Cantet, C., Cesari, M., Ousset, P., Voisin, T., Fougère, B., Guyonnet, S., Carrié, I., et al. (2016) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2016.94 · Cited by 102
Al‐Hilal, M., AlSaleh, A. F. F., Maniou, Z., Lewis, F. J., Hall, W. L., Sanders, T. A. B., & O’Dell, S. D. (2012) · Journal of Lipid Research · doi:10.1194/jlr.p032276 · Cited by 101
Einvik, G., Klemsdal, T. O., Sandvik, L., & Hjerkinn, E. M. (2010) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/hjr.0b013e328339cc70 · Cited by 100
Effects of rosuvastatin on atrial fibrillation occurrence: ancillary results of the GISSI-HF trial
Maggioni, A. P., Fabbri, G., Lucci, D., Marchioli, R., Franzosi, M. G., Latini, R., Nicolosi, G. L., Porcu, M., Cosmi, F., Stefanelli, S., et al. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp357 · Cited by 100
Walker, C. G., Browning, L. M., Mander, A., Madden, J., West, A. L., Calder, P. C., & Jebb, S. A. (2013) · British Journal Of Nutrition · doi:10.1017/s0007114513002985 · Cited by 100
Zhang, Y.-P., Miao, R., Li, Q., Wu, T., & Ma, F. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160439 · Cited by 100
Dangour, A. D., Allen, E., Elbourne, D. R., FLETCHER, A. E., Richards, M., & Uauy, R. D. (2009) · The journal of nutrition health & aging · doi:10.1007/s12603-009-0057-2 · Cited by 99
Eussen, S. R. B. M., Geleijnse, J. M., Giltay, E. J., Rompelberg, C. J. M., Klungel, O. H., & Kromhout, D. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehr499 · Cited by 99
Fehér, J., Kovàcs, B., Kovács, I., Schveoller, M., Papale, A., & Gabrieli, C. B. (2005) · Ophthalmologica · doi:10.1159/000085248 · Cited by 99
Andreeva, V. A., Kesse‐Guyot, E., Barberger‐Gateau, P., Fezeu, L., Herçberg, S., & Galan, P. (2011) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.110.006320 · Cited by 97
Fish Oil for the Reduction of Atrial Fibrillation Recurrence, Inflammation, and Oxidative Stress
Nigam, A., Talajic, M. R., Roy, D., Nattel, S., Lambert, J., Nozza, A., Jones, P. J. H., Ramprasath, V. R., O’Hara, G. E., Kopecky, S. L., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.07.956 · Cited by 96
Angerer, P., Kothny, W., Störk, S., & von Schacky, C. (2002) · Cardiovascular Research · doi:10.1016/s0008-6363(02)00229-8 · Cited by 95
Zhao, Y.-T., Chen, Q., Sun, Y.-X., Li, X.-B., Zhang, P., Xu, Y., & Guo, J.-H. (2009) · Annals of Medicine · doi:10.1080/07853890802698834 · Cited by 94
Ghio, S., Scelsi, L., Latini, R., Masson, S., Eleuteri, E., Palvarini, M., Vriz, O., Pasotti, M., Gorini, M., Marchioli, R., et al. (2010) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfq172 · Cited by 92
Ezaki, O., Takahashi, M. M., Shigematsu, T., SHIMAMURA, K., Kimura, J., EZAKI, H., & Gotoh, T. (1999) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.45.759 · Cited by 92
Fish oil in lupus nephritis: Clinical findings and methodological implications
Clark, W. F., Parbtani, A., Naylor, C. D., Levinton, C. M., Muirhead, N., Spanner, E. D., Huff, M. W., Philbrick, D. J., & Holub, B. J. (1993) · Kidney International · doi:10.1038/ki.1993.215 · Cited by 91
Enns, J. E., Yeganeh, A., Zarychanski, R., Abou-Setta, A. M., Friesen, C., Zahradka, P. C., & Taylor, C. G. (2014) · BMC Cardiovascular Disorders · doi:10.1186/1471-2261-14-70 · Cited by 91
Leng, G. C., Lee, A. J., Fowkes, F. G. R., Jepson, R. G., Lowe, G. D. O., SKINNER, E. R., & Mowat, B. (1998) · Clinical Nutrition · doi:10.1016/s0261-5614(98)80318-x · Cited by 90
Bemelmans, W. J., Lefrandt, J., Feskens, E., Broer, J., Tervaert, J., May, J., & Smit, A. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(01)00747-x · Cited by 88
Saynor, R., & Gillott, T. (1992) · Lipids · doi:10.1007/bf02536136 · Cited by 88
Nosaka, K., Miyoshi, T., Iwamoto, M., Kajiya, M., Okawa, K., Tsukuda, S., Yokohama, F., Sogo, M., Nishibe, T., Matsuo, N., et al. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.11.105 · Cited by 88
Natvig, H., Borchgrevink, C. F., Dedichen, J., OWREN, P. A., Schiøtz, E. H., & Westlund, K. (1968) · PubMed · Cited by 87
Bordeleau, L. J., Yakubovich, N., Dagenais, G. R., Rosenstock, J., Probstfield, J. L., Yu, P. C., Rydén, L., Pīrāgs, V., Spinas, G. A., Birkeland, K. I., et al. (2014) · Diabetes Care · doi:10.2337/dc13-1468 · Cited by 87
Pasternak, R. C., Brown, L. E., Stone, P. H., Silverman, D. I., Gibson, C. M., Sacks, F. M., & Harvard Atherosclerosis Reversibility Project (HARP) Study Group (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-125-7-199610010-00001 · Cited by 85
Update on the Vitamin D and OmegA-3 trial (VITAL)
Pradhan, A. D., & Manson, J. E. (2015) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2015.04.006 · Cited by 83
La Rovere, M. T., Pinna, G. D., Maestri, R., Barlera, S., Bernardinangeli, M., Veniani, M., Nicolosi, G. L., Marchioli, R., Tavazzi, L., & for the GISSI-HF Investigators (2012) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfs126 · Cited by 82
Berendsen, A., Santoro, A., Pini, E., Cevenini, E., Ostan, R., Pietruszka, B., Rolf, K., Cano, N., Caille, A., Lyon-Belgy, N., et al. (2013) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2013.10.002 · Cited by 82
Holman, R. R., Paul, S., Farmer, A., Tucker, L., Stratton, I. M., Neil, H. A. W., & on behalf of the AFORRD study group (2009) · Diabetologia · doi:10.1007/s00125-008-1179-5 · Cited by 81
Chang, C. L., & Deckelbaum, R. J. (2013) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3283616364 · Cited by 81
Eritsland, J., Arnesen, H., Seljeflot, I., & Høstmark, A. T. (1995) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/61.4.831 · Cited by 80
Rajaram, S., Valls‐Pedret, C., Cofán, M., Sabaté, J., Serra‐Mir, M., Pérez-Heras, A., Aréchiga, A. E., Casaroli-Marano, R. P., Alforja, S., Sala‐Vila, A., et al. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2016.00333 · Cited by 79
Rock, C. L., Flatt, S. W., Pakiz, B., Quintana, E. L., Heath, D. D., Rana, B. K., & Natarajan, L. (2016) · Metabolism · doi:10.1016/j.metabol.2016.07.008 · Cited by 78
Flaxseed in Lupus Nephritis: A Two-Year Nonplacebo-Controlled Crossover Study
Clark, W. F., Kortas, C., Heidenheim, A. P., Garland, J. S., Spanner, E. D., & Parbtani, A. (2001) · Journal of the American College of Nutrition · doi:10.1080/07315724.2001.10719026 · Cited by 77
Middleton, S. J., Naylor, S. J., Woolner, J. T., & Hunter, J. O. (2002) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2002.01286.x · Cited by 77
Research works printed but not linked: 83
- Geleijnse, 2011, Effects of n-3 fatty acids on cognitive decline: a randomized double-blind, placebo-controlled trial in stable myocardial infarction patients, Alzheimer's & Dementia, 1, S512, 10.1016/j.jalz.2011.05.1432 · DOI
- Brouwer, 2013, Effect of alpha linolenic acid supplementation on serum prostate specific antigen (PSA): results from the alpha omega trial, PLOS ONE, 8, e81519, 10.1371/journal.pone.0081519 · DOI
- Eussen, 2012, Effects of n-3 fatty acids on major cardiovascular events in statin users and non-users with a history of myocardial infarction, European Heart Journal, 33, 1582, 10.1093/eurheartj/ehr499 · DOI
- Geleijnse, 2011, Effects of n-3 fatty acids on cognitive decline: A randomized double-blind, placebo-controlled trial in stable myocardial infarction patients, Alzheimer's & Dementia, 1, S512, 10.1016/j.jalz.2011.05.1432 · DOI
- Geleijnse, 2012, Effects of n-3 fatty acids on cognitive decline: a randomized, double-blind, placebo-controlled trial in stable myocardial infarction patients, Alzheimer's & Dementia, 8, 278, 10.1016/j.jalz.2011.06.002 · DOI
- Geleijnse, 2010, Effect of low doses of n-3 fatty acids on cardiovascular diseases in 4,837 post-myocardial infarction patients: design and baseline characteristics of the Alpha Omega Trial, American Heart Journal, 159, 539, 10.1016/j.ahj.2009.12.033 · DOI
- Giltay, 2012, No effects of n-3 fatty acid supplementation on serum total testosterone levels in older men: the Alpha Omega Trial, International Journal of Andrology, 35, 680, 10.1111/j.1365-2605.2012.01255.x · DOI
- Giltay, 2011, Effects of n-3 fatty acids on depressive symptoms and dispositional optimism after myocardial infarction, American Journal of Clinical Nutrition, 94, 1442, 10.3945/ajcn.111.018259 · DOI
- Hoogeveen, 2012, Effects of N-3 fatty acids on decline of kidney function after myocardial infarction: Alpha Omega Trial, Nephrology Dialysis Transplantation, 27, ii64
- Hoogeveen, 2014, No effect of n-3 fatty acids on high-sensitivity C-reactive protein after myocardial infarction: the Alpha Omega Trial, European Journal of Preventive Cardiology, 21, 1429, 10.1177/2047487313494295 · DOI
- Hoogeveen, 2014, Effect of omega-3 fatty acids on kidney function after myocardial infarction: the Alpha Omega Trial, Clinical Journal of The American Society of Nephrology: CJASN, 9, 1676, 10.2215/CJN.10441013 · DOI
- Kromhout, 2011, N-3 fatty acids, ventricular arrhythmia-related events, and fatal myocardial infarction in post myocardial infarction patients with diabetes, Diabetes Care, 34, 2515, 10.2337/dc11-0896 · DOI
- Kromhout, 2010, N-3 fatty acids and cardiovascular events after myocardial infarction, New England Journal of Medicine, 363, 2015, 10.1056/NEJMoa1003603 · DOI · Paper page
- Burr, 1989, Fish and the heart, Lancet, ii, 1451
- Harrison, 2005, Dietary Intervention for Maintaining Sinus Rhythm Following Cardioversion for Atrial Fibrillation: a Randomised Controlled Trial [PhD thesis]
- Harrison, 2003, Using community-based dietary assistants to increase the intake of oil-rich fish among older people, European Journal of Public Health, 13, 105
- Doi, 2014, Clinical outcomes of early initiation of pure eicosapentaenoic acid supplement after percutaneous coronary intervention in patients with acute coronary syndrome, European Heart Journal, 35, 1156
- Feagan, 2008, Omega-3 free fatty acids for the maintenance of remission in Crohn disease: the EPIC randomized controlled trials, JAMA, 229, 1690, 10.1001/jama.299.14.1690 · DOI · Paper page
- Erdogan, 2007, Omega AF study: polyunsaturated fatty acids (PUFA) for prevention of atrial fibrillation relapse after successful external cardioversion, Heart Rhythm, 4, S185
- Edel, 2013, Flaxseed lignan metabolites elicit antihypertensive effects in pad patients in the flax-pad trial, Annals of Nutrition and Metabolism, 63, 1339
- Pierce, 2014, The use of dietary flaxseed to promote cardiovascular health, Acta Physiologica, 211, 15
- Pierce, 2013, The clinical use of flaxseed as a powerful nutritional intervention to treat cardiovascular disease, Cardiology (Switzerland), 126, 201
- Gill, 2014, Omega-3 fatty acids effects on carotid IMT in metabolic syndrome, Circulation, 130, A1269. Abstract
- Finzi, 2009, Antiarrhythmic effects of n-3 PUFA in patients with heart failure and an implantable cardioverter defibrillator in the GISSI-HF trial, European Heart Journal, 30, 279
- Rovere, 2011, Effect of n-3PUFA on heart rate variability. Data from the GISSI-HF holter substudy, Circulation, 124, A14829
- Latini, 2011, Circulating levels of n-3 polyunsaturated fatty acids in patients with chronic heart failure. Data from the GISSI-HF trial, European Heart Journal, 32, 919
- Marchioli, 2009, Time course analysis of the effect of n-3 PUFA on fatal and non fatal arrhythmias in heart failure: secondary results of the GISSI-HF trial, European Heart Journal, 30, 165
- Marchioli, 2009, Time course analysis of the effect of n-3 PUFA on fatal and non fatal heart failure: secondary results of the GISSI-HF trial, European Heart Journal, 30, 432
- Marchioli, 2009, Prognostic ability of a Mediterranean dietary score in heart failure: preliminary analysis of the GISSI-Heart failure Trial, European Heart Journal, 30, 1026
- Marchioli, 2009, Effect of n-3 PUFA in heart failure patients with different dietary habits: preliminary results of the GISSI-heart failure trial, European Heart Journal, 30, 426
- Marchioli, 2009, Effect of n-3 PUFA according to fish intake: preliminary results of GISSI-Heart Failure, European Heart Journal, 30, 707
- Tan, 2010, Dietary Manipulation and Weight Management [PhD thesis]
- Delrieu, 2011, Multidomain alzheimer's disease preventive trial: florbetapir ancillary study, Alzheimer's and Dementia, 1, S419, 10.1016/j.jalz.2011.05.1217 · DOI
- Gillette, 2009, The multidomain Alzheimer preventive trial (MAPT): a new approach for the prevention of Alzheimer's disease, Alzheimer's & Dementia, S4-02-05, 145, 10.1016/j.jalz.2009.05.496 · DOI
- Gillette-Guyonnet, 2011, MAPT study: a 3-year randomized trial of omega 3 and/or multidomain intervention for the prevention of cognitive decline in frail elderly subjects-rationale, design and baseline data, Alzheimer's & Dementia, 1, S97
- Vellas, 2012, MAPT (multidomain Alzheimer preventive trial) imaging (MRI, FDG-PET, amyloid-PET) data, Journal of Nutrition, Health and Aging, 16, 812
- Pinto, 2015, Effect of low doses of long chain n-3 PUFA intake on daytime heart rate variability: results from the MARINA study, European Journal of Preventive Cardiology, 1, S146
- Nodari, 2010, Effects of n-3 polyunsaturated fatty acids on left ventricular function and functional capacity in heart failure patients, European Heart Journal, 31, 850
- Nodari, 2012, Plasma levels of n-3 polyunsaturated fatty acids and risk of hospitalization in patients with non-ischemic cardiomyopathy, Circulation. Conference: American Heart Association, 126, A17431
- Ilsey, 1987, Randomised placebo controlled trial of MAXEPA and aspirin/persantin after successful coronary angioplasty, Australian & New Zealand Journal of Medicine, 17, 559
- Naesgaard, 2014, The effect on vitamin D levels of long-term high-dose treatment with a concentrated omega-3 compound (Omacor/Lovaza) in patients hospitalized with a myocardial infarction, Circulation, 130, A17245
- Poenitz, 2012, Pentraxin 3 is uninfluenced by high doses of concentrated omega-3 fatty acids administered for 12 months following an acute myocardial infarction, Circulation. Conference: American Heart Association, 126, A13464
- Bordeleau, 2013, Cancer outcomes in patients with dysglycemia on basal insulin: results of the Origin trial, Diabetes, 62, A72
- Proudman, 2012, Fish oil in rheumatoid arthritis: a randomised, double blind trial comparing high dose with low dose, Internal Medicine Journal, 42, 2
- Eritsland, 1994, Effect of supplementation with n-3 fatty acids on graft patency in patients undergoing coronary artery bypass operation. Results from SHOT study, European Heart Journal, 15, 29
- Eritsland, 1993, Long-term influence of omega-3 fatty acids on fibrinolysis, fibrinogen, and serum lipids, Thrombosis and Haemostasis, 69, 1065
- Galan, 2008, The SU.FOL.OM3 Study: a secondary prevention trial testing the impact of supplementation with folate and B-vitamins and/or Omega-3 PUFA on fatal and non fatal cardiovascular events, design, methods and participants characteristics, Trials, 9, 35, 10.1186/1745-6215-9-35 · DOI
- Galan, 2009, The scientific basis of the SU.FOL.OM3 study: a secondary intervention trial of folate, B6 and B12 vitamins and/or omega3 fatty acid supplements in the prevention of recurrent ischemic events, Sang Thrombose Vaisseaux, 21, 207
- Galan, 2009, The scientific basis of the SU.FOL.OM3 study: a secondary intervention trial of folate, B6 and B12 vitamins and/or omega3 fatty acid supplements in the prevention of recurrent ischemic events, Sang Thrombose Vaisseaux, 21, 207
- McCormick, 2015, Peripheral sensory nerve function is independently associated with microvascular function, but neither are improved by n-3 fatty acids, Diabetic Medicine, 32, 99
- Scorletti, 2014, Potential benefits of purified long chainomega-3 fatty acid treatment in non-alcoholic fatty liver disease (NAFLD): a potential treatment for early NAFLD in metabolic syndrome and type 2 diabetes? Results from the WELCOME study, Diabetic Medicine, 31, 1
- Baleztena Gurrea, 2015, Utility of heavy food supplement in omega-3 fatty acids in the prevention of dementia, in relation to the basal nutritional level, in people of advanced age: randomized multicenter study, Revista Española de Geriatría y Gerontología, 50, 1
- Bes-Rastrollo, 2015, Utility of a rich food supplement Omega-3 fatty acids in the prevention of dementia, in relation to baseline nutritional level, in people with advanced age: multicentre randomised study, Nutrición Clínica en Medicina, 9, 38
- Cheng, 1990, The effect of omega-3 fatty acids on restenosis after coronary angioplasty, European Heart Journal, 11, 368
- Fonolla, 2011, Daily intake of a low lactose dairy drink enriched with omega-3 (EPA+DHA), oleic acid and calcium improves nutritional and bone status in healthy postmenopausal women, Clinical Nutrition, 6, 86
- Franzen, 1989, Long-term effect of fish oil and olive oil on plasma lipids in patients with CHD, Zeitschrift fur Kardiologie, 78, 28
- Gapparova, 2000, Effects of omega-3 polyunsaturated fatty acids of vegetable and animal origin on clinical and metabolic indicators and the intensity of lipid peroxidation in patients with ischemic heart disease and impaired carbohydrate tolerance, Voprosy Pitaniia, 69, 46
- Hashimoto, 2011, Beneficial effects of dietary docosahexaenoic acid intervention on cognitive function in elderly people with very mild dementia in Japan, Alzheimer's and Dementia, 1, S610
- Hashimoto, 2012, Beneficial effects of daily dietary omega-3 polyunsaturated fatty acid supplementation on age related cognitive decline in elderly Japanese with very mild dementia: a 2-year randomized,double-blind, placebo-controlled trial, Journal of Aging Research & Clinical Practice, 1, 193
- Lau, 1991, Effects of Maxepa on non-steroidal anti-inflammatory drug useage in patients with mild rheumatoid arthritis, British Journal of Rheumatology, 30, 137
- Lorgeril, 1999, Does a Mediterranean dietary pattern prolong survival?, Cardiology Review, 16, 30
- Mantzaris, 1996, A prospective, randomized, placebo-controlled study of fish oil in ulcerative colitis, Hellenic Journal of Gastroenterology, 9, 138
- Mate, 1991, Does dietary fish oil maintain the remission of Crohn's disease: a study case control, Gastroenterology, 100, A228
- Colquhoun, 1997, Rationale and design of the "OLIVE" study (comparison of an olive oil enriched to a low fat diet intervention study using vascular endpoints), Atheroscerosis, 134, 326
- Colquhoun, 1998, Comparison of an olive oil enriched diet to a low fat diet intervention study using vascular endpoints: assessed by repeat quantitative angiography (OLIVE study), Australian Journal of Nutrition and Dietetics, 55, S24
- Meilahn, 1990, Coagulation parameters among healthy adults taking fish oil versus placebo, Arteriosclerosis, 10, 916A
- Singh, 2012, Effect of low W-6/W-3 fatty acid ratio Paleolithic style diet in patients with acute coronary syndromes: a randomized, single blind, controlled trial, World Heart Journal, 4, 71
- Singh, 1997, Randomized, double-blind, placebo-controlled trial of fish oil and mustard oil in patients with suspected acute myocardial infarction: the Indian experiment of infarct survival 4, Cardiovascular Drugs and Therapy, 11, 485, 10.1023/A:1007757724505 · DOI · Paper page
- Bowman, 2012, ASCEND: design and baseline characteristics of a large randomised trial in diabetes, Diabetes, 61, A556
- Chandrakala, 2012, Low-fat (< 20%) diets prevent type 2 diabetes mellitus, Diabetes, 61, A190
- Laake, 2014, Effects of omega 3 supplementation in elderly patients with acute myocardial infarction: design of a prospective randomized placebo controlled study, BMC Geriatrics, 14, 74, 10.1186/1471-2318-14-74 · DOI
- Shinto, 2015, Omega 3 fatty acids for the prevention of vascular cognitive aging: methods and rationale for a phase II trial, Alzheimer's & Dementia, 11, 610, 10.1016/j.jalz.2015.06.847 · DOI
- Gold, 2014, Baseline chronic obstructive pulmonary disease in the lung vitamin D and omega-3 trial, American Journal of Respiratory and Critical Care Medicine, 189, D44 COPD
- Kang, 2015, Cognitive substudy of the vitamin d and omega-3 trial (vital-cog): design of a large randomized trial of omega-3 and vitamin d supplements in relation to cognitive change, Alzheimer's & Dementia, 1, 608, 10.1016/j.jalz.2015.06.843 · DOI
- Manson, 2010, Vitamin D and cancer and cardiovascular disease: ready for prime time?, Menopause, 17, 1215
- Abdelhamid, 2017, Polyunsaturated fatty acids for musculoskeletal health and functional status in older adults, PROSPERO, www.crd.york.ac, CRD42017079211
- Hanson, 2017, Dietary polyunsaturated fat for prevention and treatment of depression and anxiety, PROSPERO, www.crd.york.ac, CRD42017056092
- Higgins JP Altman DG Sterne JAC editor(s) Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org
- Jimoh, 2017, Dietary polyunsaturated fat for prevention and treatment of neurocognitive disorders, PROSPERO, www.crd.york.ac, CRD42017019049
- Lefebvre C Manheimer E Glanville J Chapter 6: Searching for studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org
- Liem, 1997, Dioxins: Chemical Analysis, Exposure and Risk Assessment
- Mariani, 2013, N-3 polyunsaturated fatty acids to prevent atrial fibrillation: updated systematic review and meta-analysis of randomized controlled trials, Journal of the American Heart Association, 2, e005033, 10.1161/JAHA.112.005033 · DOI
- Thorpe, 2017, Dietary polyunsaturated fat for prevention and treatment of inflammatory bowel disease, PROSPERO, www.crd.york.ac, CRD42017068704
Cited by
Mach, F., Baigent, C., Catapano, A. L., Koskinas, K. C., Casula, M., Badimon, L., Chapman, M. J., De Backer, G. G., Delgado, V., Ference, B. A., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz455 · Cited by 8,961
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
Visseren, F. L. J., Mach, F., Smulders, Y. M., Carballo, D., Koskinas, K. C., Bäck, M., Benetos, A., Biffi, A., Boavida, J.-M., Capodanno, D., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab484 · Cited by 6,485
Mach, F., Baigent, C., Catapano, A. L., Koskinas, K. C., Casula, M., Badimon, L., Chapman, M. J., De Backer, G. G., Delgado, V., Ference, B. A., et al. (2019) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2019.08.014 · Cited by 4,854
Lichtenstein, A. H., Appel, L. J., Vadiveloo, M., Hu, F. B., Kris-Etherton, P. M., Rebholz, C. M., Sacks, F. M., Thorndike, A. N., Van Horn, L., Wylie-Rosett, J., et al. (2021) · Circulation · doi:10.1161/cir.0000000000001031 · Cited by 1,065
Pearson, G. J., Thanassoulis, G., Anderson, T. J., Barry, A. R., Couture, P., Dayan, N., Francis, G. A., Genest, J., Grégoire, J., Grover, S. A., et al. (2021) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2021.03.016 · Cited by 843
Metadata
- Authors
- Abdelhamid, A. S., Brown, T. J., Brainard, J. S., Biswas, P., Thorpe, G. C., Moore, H. J., Deane, K. H., AlAbdulghafoor, F. K., Summerbell, C. D., Worthington, H. V., Song, F., & Hooper, L.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2018-11-30
- Volume
- 11
- Pages
- CD003177-CD003177
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W4243760090
- Cited by
- 405
- References
- 443
- FWCI
- 38.20
- Type
- journal article
- Language
- en
- Update notices
- new_version (2020-02-29)
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.